Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan and Fludarabine Conditioning for Stem Cell Transplant
NCT00301912Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Jan 2002
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan, fludarabine in chronic myelogenous leukemia (CML), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (ALL), aplastic anemia, sponsored by University of California, San Francisco. Planned start Jan 2002; status: withdrawn.
02
Drugs
busulfanfludarabine
03
Conditions
chronic myelogenous leukemia (CML)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)acute lymphoblastic leukemia (ALL)aplastic anemia
Beyond the preview
Go deeper on NCT00301912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301912.